Koers Sirona Biochem Corp Toronto S.E.
Aandelen
SBM
CA82967M1005
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 672K 491K 459K | Omzet 2023 | 34,78K 25,39K 23,78K | Marktkapitalisatie | 21,44 mln. 15,65 mln. 14,66 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,19 mln. -2,05 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,46 mln. -1,37 mln. | EV/omzet 2022 | 48,8 x |
Nettoschuld 2022 | 48,04K 35,07K 32,85K | Nettoschuld 2023 | 1,61 mln. 1,18 mln. 1,1 mln. | EV/omzet 2023 | 663 x |
K/w-verhouding 2022 |
-8,81
x | K/w-verhouding 2023 |
-8,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 89,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 | |
Chief Tech/Sci/R&D Officer | - | 31-03-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Alex Marazzi
BRD | Director/Board Member | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,87% | 52,73 mld. | |
+37,35% | 39 mld. | |
-9,45% | 38,52 mld. | |
+27,44% | 30,38 mld. | |
-12,26% | 26,39 mld. | |
+10,73% | 26,08 mld. | |
+44,44% | 14,15 mld. | |
+32,12% | 12,6 mld. | |
-5,38% | 11,51 mld. |